Medicines Discovery Catapult and AstraZeneca collaborate to overcome the bottlenecks in early drug discovery
Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751
Medicines Discovery Catapult: supporting UK industry – an interview with Robin Brown
Using artificial intelligence to predict outcomes of organic chemistry at IBM Research – Zurich
Could a small molecule complement regenerative therapies in spinal cord injury?
On the virtues of automated quantitative structure–activity relationship: the new kid on the block